Top Buy
| Wertpapier | Buy | Sell | Buy (1M) | Sell (1M) | Kurs | Kursziel | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 74 | 0 | 11 | 0 | 807,70 € | 831,01 € | 2,89 % |
| Vertex Pharmaceuticals Inc. | 58 | 2 | 1 | 0 | 414,75 € | 439,34 € | 5,93 % |
| Regeneron Pharmaceuticals Inc. | 53 | 1 | 7 | 0 | 922,40 € | 1.080,6 € | 17,15 % |
| Insmed Inc. | 46 | 0 | 2 | 0 | 64,50 € | 76,89 € | 19,20 % |
| Alnylam Pharmace. | 44 | 0 | 3 | 0 | 244,10 € | 275,25 € | 12,76 % |
| Johnson & Johnson | 41 | 1 | 6 | 0 | 146,04 € | 192,63 € | 31,90 % |
| Intra-Cellular Therapies Inc. | 36 | 0 | 5 | 0 | 66,50 € | 85,14 € | 28,03 % |
| Cytokinetics Inc. | 37 | 1 | 5 | 0 | 52,00 € | 82,73 € | 59,09 % |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | 14,05 € | 29,92 € | 113,00 % |
| AbbVie Inc. | 33 | 0 | 0 | 0 | 176,98 € | 181,45 € | 2,52 % |
| Jazz Pharmaceuticals plc | 33 | 0 | 3 | 0 | 99,66 € | 182,69 € | 83,31 % |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | 100,00 € | 126,38 € | 26,38 % |
| United Therapeutics | 29 | 1 | 2 | 0 | 324,20 € | 341,70 € | 5,40 % |
| Amgen Inc. | 29 | 1 | 3 | 1 | 291,20 € | 304,82 € | 4,68 % |
| Ultragenyx Pharmaceutical Inc. | 29 | 1 | 5 | 0 | 49,00 € | 82,93 € | 69,25 % |
| Icon plc | 27 | 0 | 5 | 0 | 267,30 € | 327,46 € | 22,51 % |
| Halozyme Therapeutics Inc. | 25 | 0 | 4 | 0 | 53,94 € | 58,58 € | 8,60 % |
| Trinity Biotech ADR | 25 | 0 | 0 | 0 | 0,41 € | - | - |
| Pfizer Inc. | 29 | 4 | 5 | 0 | 26,04 € | 40,64 € | 56,08 % |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | 105,00 € | 144,48 € | 37,60 % |
| Celldex Therapeutics | 23 | 0 | 6 | 0 | 28,00 € | 62,17 € | 122,03 % |
| Abbott Laboratories | 22 | 0 | 3 | 0 | 102,60 € | 116,48 € | 13,53 % |
| Exelixis Inc. | 22 | 0 | 4 | 0 | 23,95 € | 26,01 € | 8,59 % |
| Zoetis Inc. A | 22 | 1 | 1 | 0 | 173,08 € | 196,17 € | 13,34 % |
| Pacira Pharmaceuticals | 22 | 1 | 1 | 0 | 14,10 € | 40,02 € | 183,83 % |